Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6930896> ?p ?o }
Showing triples 1 to 30 of
30
with 100 triples per page.
- Q6930896 subject Q8872471.
- Q6930896 subject Q8878163.
- Q6930896 subject Q9062056.
- Q6930896 abstract "Mubritinib (TAK-165) is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. It completed phase I clinical trials but appears to have been discontinued, as no new information on the drug has surfaced since December 2008.".
- Q6930896 atcPrefix "none".
- Q6930896 casNumber "366017-09-6".
- Q6930896 fdaUniiCode "V734AZP9BR".
- Q6930896 iupacName "1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole".
- Q6930896 pubchem "6444692".
- Q6930896 thumbnail Mubritinib_2.svg?width=300.
- Q6930896 wikiPageWikiLink Q12078.
- Q6930896 wikiPageWikiLink Q30612.
- Q6930896 wikiPageWikiLink Q7251487.
- Q6930896 wikiPageWikiLink Q8872471.
- Q6930896 wikiPageWikiLink Q8878163.
- Q6930896 wikiPageWikiLink Q899133.
- Q6930896 wikiPageWikiLink Q9062056.
- Q6930896 atcPrefix "none".
- Q6930896 casNumber "366017".
- Q6930896 iupacName "1".
- Q6930896 pubchem "6444692".
- Q6930896 unii "V734AZP9BR".
- Q6930896 type ChemicalSubstance.
- Q6930896 type Drug.
- Q6930896 type ChemicalObject.
- Q6930896 type Thing.
- Q6930896 type Q8386.
- Q6930896 comment "Mubritinib (TAK-165) is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. It completed phase I clinical trials but appears to have been discontinued, as no new information on the drug has surfaced since December 2008.".
- Q6930896 label "Mubritinib".
- Q6930896 depiction Mubritinib_2.svg.